Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

Robin E. Norris, Elizabeth Fox, Joel M. Reid, Andrew Ralya, Xiaowei W. Liu, Charles Minard, Brenda J. Weigel

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)'. Together they form a unique fingerprint.

Medicine & Life Sciences